Subscription for Prostate Cancer Newsletter | Us Too International

Receive emails from Us TOO including the HotSheet e-newsletter and the latest Prostate Cancer News You Can Use each month.

Subscribe to the news feed and emails from Us TOO.

Click here to Subscribe

Us TOO Prostate Cancer NEWS You Can Use


Supported by

image1
image2
 

Early evidence of increase in higher-risk prostate cancers from 2011-2013

By a News Reporter-Staff News Editor at Cancer Weekly -- ASCO Perspective: "This study, while preliminary, adds new insight to the ongoing debate on the risks and benefits of PSA

Patients with detectable PSA post-prostatectomy should receive more aggressive radiation therapy

By a News Reporter-Staff News Editor at Clinical Trials Week -- Fairfax, Va., Prostate cancer patients with detectable prostate specific antigen (PSA) following radical

Two major studies strengthen case for prostate cancer drug before chemotherapy

By a News Reporter-Staff News Editor at Clinical Trials Week -- Pioneering prostate cancer drug abiraterone significantly extends the lives of men with advanced prostate cancer if

New Prostate Cancer Data Have Been Reported by Investigators at University of California (Cost Implications and Complications of Overtreatment of...

New Prostate Cancer Data Have Been Reported by Investigators at University of California (Cost Implications and Complications of Overtreatment of Low-Risk Prostate Cancer in the

New Findings on Prostate Cancer from Fourth Military Medical University Summarized (MLF1 interacting protein: a potential gene therapy target for...

New Findings on Prostate Cancer from Fourth Military Medical University Summarized (MLF1 interacting protein: a potential gene therapy target for human prostate cancer?) By a News

Reports from University of Washington Advance Knowledge in Prostate Cancer (Efficacy Studies of an Antibody-Drug Conjugate PSMA-ADC in...

Reports from University of Washington Advance Knowledge in Prostate Cancer (Efficacy Studies of an Antibody-Drug Conjugate PSMA-ADC in Patient-Derived Prostate Cancer Xenografts

New study reveals how to improve chemotherapy use in prostate cancer

By a News Reporter-Staff News Editor at Biotech Week -- (PHILADELPHIA) - Prostate cancer is the second leading cause of cancer for men in the United States. Only one class of

Researchers from Johns Hopkins University Report New Studies and Findings in the Area of Prostate Cancer (Combining the pan-aurora kinase inhibitor...

Researchers from Johns Hopkins University Report New Studies and Findings in the Area of Prostate Cancer (Combining the pan-aurora kinase inhibitor AMG 900 with histone deacetylase

Findings from University of Chicago Hospital Has Provided New Data on Prostate Cancer (Late toxicity and quality of life after definitive treatment...

Findings from University of Chicago Hospital Has Provided New Data on Prostate Cancer (Late toxicity and quality of life after definitive treatment of prostate cancer: redefining

Aduro Meets Development Milestone in Immuno-Oncology Collaboration with Janssen for Treatment of Prostate Cancer

By a News Reporter-Staff News Editor at Biotech Week -- Aduro Biotech, Inc. announced that it has achieved its first milestone under its collaboration with Janssen Biotech, Inc

New Prostate Cancer Findings Has Been Reported by M.S. Broder et al (Burden of skeletal-related events in prostate cancer: unmet need in pain...

New Prostate Cancer Findings Has Been Reported by M.S. Broder et al (Burden of skeletal-related events in prostate cancer: unmet need in pain improvement) By a News Reporter-Staff

Findings from Peter MacCallum Cancer Center in the Area of Prostate Cancer Described (The effects of nonspecific HIF1 alpha inhibitors on development...

Findings from Peter MacCallum Cancer Center in the Area of Prostate Cancer Described (The effects of nonspecific HIF1 alpha inhibitors on development of castrate resistance and

Investigators at University Health Network Discuss Findings in Prostate Cancer (Efficacy and toxicity of abiraterone and docetaxel in octogenarians...

Investigators at University Health Network Discuss Findings in Prostate Cancer (Efficacy and toxicity of abiraterone and docetaxel in octogenarians with metastatic castration-

OICR extends collaboration with Janssen Inc. to develop clinical trials for prostate cancer

TORONTO, Feb. 25, 2015 /CNW/ - The Ontario Institute for Cancer Research (OICR) is extending its collaborative research partnership with Janssen Inc. to develop more multi-centre

Data on Prostate Cancer Reported by Researchers at University Campus of Biomedicine (Somatostatin analogs and disease control in castration-resistant...

Data on Prostate Cancer Reported by Researchers at University Campus of Biomedicine (Somatostatin analogs and disease control in castration-resistant prostate cancer: different

New Prostate Cancer Data Have Been Reported by Researchers at Indiana University School of Medicine (Targeting Prostate-specific Membrane Antigen For...

New Prostate Cancer Data Have Been Reported by Researchers at Indiana University School of Medicine (Targeting Prostate-specific Membrane Antigen For Personalized Therapies In

Data from University Hospital Advance Knowledge in Prostate Cancer (Radium 223 dichloride: a multidisciplinary approach to metastatic...

Data from University Hospital Advance Knowledge in Prostate Cancer (Radium 223 dichloride: a multidisciplinary approach to metastatic castration-resistant prostate cancer) By a

Studies from University of Rochester Yield New Information about Prostate Cancer (Evidence of histidine and aspartic acid phosphorylation in human...

Studies from University of Rochester Yield New Information about Prostate Cancer (Evidence of histidine and aspartic acid phosphorylation in human prostate cancer cells) By a News

Investigators from Oregon Health and Science University Zero in on Prostate Cancer (Resistance Training Reduces Disability in Prostate Cancer...

Investigators from Oregon Health and Science University Zero in on Prostate Cancer (Resistance Training Reduces Disability in Prostate Cancer Survivors on Androgen Deprivation

Recent Research from University Medical Center Highlight Findings in Prostate Cancer (CAST: A retrospective analysis of cabazitaxel and abiraterone...

Recent Research from University Medical Center Highlight Findings in Prostate Cancer (CAST: A retrospective analysis of cabazitaxel and abiraterone acetate sequential treatment in

Reports from Technical University Provide New Insights into Prostate Cancer (Targeting Bone Metabolism in Patients with Advanced Prostate Cancer:...

Reports from Technical University Provide New Insights into Prostate Cancer (Targeting Bone Metabolism in Patients with Advanced Prostate Cancer: Current Options and Controversies

New Prostate Cancer Findings from Memorial Sloan-Kettering Cancer Center Outlined [Abiraterone acetate plus prednisone versus placebo plus prednisone...

New Prostate Cancer Findings from Memorial Sloan-Kettering Cancer Center Outlined [Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with

Findings from Johns Hopkins University Reveals New Findings on Prostate Cancer (Understanding the Mechanisms of Androgen Deprivation Resistance in...

Findings from Johns Hopkins University Reveals New Findings on Prostate Cancer (Understanding the Mechanisms of Androgen Deprivation Resistance in Prostate Cancer at the Molecular

Payne Introduces Resolution to Protect Quality of Life for Prostate Cancer Survivors

Washington, D.C. - Congressman Donald M. Payne, Jr. (NJ-10) joined with Congressman Erik Paulsen (MN-03) to introduce a resolution to protect the quality of life for prostate

Slaying prostate cancer with saffron

Saffron’s been used in traditional medicine for more than 3,000 years, as everything from an aphrodisiac to an antidote to poison. Could it hold the key to fighting the second-

OPKO Announces Publication of 20 Year Outcome Study for Lethal Prostate Cancer Using Kallikrein Biomarkers in 4Kscore Test

By a News Reporter-Staff News Editor at Cancer Weekly -- OPKO Health, Inc. (NYSE:OPK) announced the online publication of a study entitled "Improving the Specificity of Screening

Bristol-Myers enters into $975m deal for Bavarian Nordic's Prostvac to treat prostate cancer

Bristol-Myers Squibb has entered into a $975m option and licensing deal with Danish biotech firm Bavarian Nordic for its prostate-cancer vaccine candidate Prostvac. Under the deal

Innocrin Pharmaceuticals Inc. to Present Interim Results from Its Phase 1/2 Prostate Cancer Clinical Study and Preclinical Results That Demonstrate...

Innocrin Pharmaceuticals Inc. to Present Interim Results from Its Phase 1/2 Prostate Cancer Clinical Study and Preclinical Results That Demonstrate VT-464 Efficacy in a Clinically-

New health care delivery model for prostate cancer care results in better patient outcomes

By a News Reporter-Staff News Editor at Cancer Weekly -- PASADENA, Calif., A comprehensive, population-based regional health care management program for men with prostate cancer

Active surveillance of intermediate-risk prostate cancer associated with decreased survival

By a News Reporter-Staff News Editor at Cancer Weekly -- ALEXANDRIA, Va. - An analysis of data on 945 patients with prostate cancer that is managed with active surveillance shows

GenomeDx's Decipher Shows Broad Applicability in Advancing Prostate Cancer Care in Data Presented at 2015 ASCO Genitourinary Symposium

By a News Reporter-Staff News Editor at Drug Week -- GenomeDx Biosciences announced that data presented at the 2015 ASCO Genitourinary Symposium shows further development of its

New target for prostate cancer treatment discovered by Keck Medicine of USC researchers

By a News Reporter-Staff News Editor at Biotech Week -- LOS ANGELES -- Keck Medicine of the University of Southern California (USC) scientists have found a promising new

BWH study provides evidence for new approaches to prostate cancer

By a News Reporter-Staff News Editor at Cancer Weekly -- BOSTON, MA -Monitoring prostate cancer (PC) by active surveillance (AS), with the expectation to initiate treatment if the

Exosome Diagnostics Announces Positive Results from Initial Clinical Study of Novel Prostate Cancer Liquid Biopsy

By a News Reporter-Staff News Editor at Cancer Weekly -- Exosome Diagnostics, Inc., a developer of revolutionary, biofluid-based molecular diagnostics, announced positive data from

Reports on Radiotherapy from Northeastern University Provide New Insights (Brachytherapy Application With In Situ Dose Painting Administered by Gold...

Reports on Radiotherapy from Northeastern University Provide New Insights (Brachytherapy Application With In Situ Dose Painting Administered by Gold Nanoparticle Eluters) By a News

Report Summarizes Prostate Cancer Study Findings from University Hospital (Defining a Standard Set of Patient-centered Outcomes for Men with...

Report Summarizes Prostate Cancer Study Findings from University Hospital (Defining a Standard Set of Patient-centered Outcomes for Men with Localized Prostate Cancer) By a News

New Prostate Cancer Data Have Been Reported by Researchers at Autonomous University (Estimating Preferences for Treatments in Patients With Localized...

New Prostate Cancer Data Have Been Reported by Researchers at Autonomous University (Estimating Preferences for Treatments in Patients With Localized Prostate Cancer) By a News

Cellanyx Diagnostics Announces First Clinical Data with a Novel Live Tumor Cell, Phenotypic Biomarker Test in Prostate Cancer

By a News Reporter-Staff News Editor at Cancer Weekly -- Cellanyx Diagnostics announced that it will present at the ASCO Genitourinary Cancers Symposium, in Orlando, Florida, their

Prostate cancer diagnostic options: past, present and future

Prostate cancer (PCa) has one of the highest incidence rates in the developed world, affecting one in seven men.1 (Please visit www.mlo-online to read references for this article

Surprise: High-dose testosterone therapy helps some men with advanced prostate cancer

By a News Reporter-Staff News Editor at Biotech Week -- In a surprising paradox, the male hormone testosterone, generally thought to be a feeder of prostate cancer, has been found

Vanderbilt-led team studies blood test for prostate cancer

By a News Reporter-Staff News Editor at Cancer Weekly -- Vanderbilt University researcher William Mitchell, M.D., Ph.D., and colleagues in Germany and Canada have demonstrated a

Boxer, Sessions Introduce Bill to Support Prostate Cancer Research

Washington, D.C. - U.S. Senators Barbara Boxer (D-CA) and Jeff Sessions (R-AL) today introduced legislation to fight prostate cancer. The National Prostate Cancer Plan Act would

Medivation and Astellas Pharma Reports Results from Phase 2 Terrain Trial

Medivation and Astellas Pharma reported topline results from the Phase 2 Terrain trial comparing enzalutamide with bicalutamide in men with metastatic castration-resistant prostate

Novel imaging technique improves prostate cancer detection

By a News Reporter-Staff News Editor at Cancer Weekly -- In 2014, issue of the journal Prostate Cancer and Prostatic Disease, a team of scientists and physicians from the

New study findings help physicians and patients determine prostate cancer risk

By a News Reporter-Staff News Editor at Cancer Weekly -- SALT LAKE CITY--A discovery by researchers at Huntsman Cancer Institute shows that looking at whether a man's uncles and

Data on Prostate Cancer Reported by Researchers at Harvard University (Radionuclide Therapy for Osseous Metastases in Prostate Cancer)

By a News Reporter-Staff News Editor at Cancer Vaccine Week -- Research findings on Oncology are discussed in a new report. According to news reporting from Boston, Massachusetts

Researchers from University of Southern Florida Report New Studies and Findings in the Area of Prostate Cancer (Informed decision making among...

Researchers from University of Southern Florida Report New Studies and Findings in the Area of Prostate Cancer (Informed decision making among first-degree relatives of prostate

Investigators at Wake Forest University Report Findings in Prostate Cancer (A genetic-based approach to personalized prostate cancer screening and...

Investigators at Wake Forest University Report Findings in Prostate Cancer (A genetic-based approach to personalized prostate cancer screening and treatment) By a News Reporter-

New Incontinence Findings from Department of Surgery Reported (Characteristics and outcomes of men who fail to leak on intubated urodynamics prior to...

New Incontinence Findings from Department of Surgery Reported (Characteristics and outcomes of men who fail to leak on intubated urodynamics prior to artificial urinary sphincter

Sipuleucel-T in prostate cancer: Added benefit is not proven

By a News Reporter-Staff News Editor at Clinical Trials Week -- Sipuleucel-T (trade name Provenge) has been approved since September 2014 for men with metastatic prostate cancer

New Findings from Cancer Care of Ontario in the Area of Prostate Cancer Described (Prehabilitation for men undergoing radical prostatectomy: a...

New Findings from Cancer Care of Ontario in the Area of Prostate Cancer Described (Prehabilitation for men undergoing radical prostatectomy: a multi-centre, pilot randomized

Researchers at NorthShore University Health System Have Reported New Data on Prostate Specific Antigen (Primary care physician PSA screening...

Researchers at NorthShore University Health System Have Reported New Data on Prostate Specific Antigen (Primary care physician PSA screening practices before and after the final US

Investigators at Harvard University Discuss Findings in Prostate Cancer (Calcium and phosphorus intake and prostate cancer risk: a 24-y follow-up...

Investigators at Harvard University Discuss Findings in Prostate Cancer (Calcium and phosphorus intake and prostate cancer risk: a 24-y follow-up study) By a News Reporter-Staff

Data on Prostate Cancer Detailed by S.E. Finkelstein and Co-Authors (Combining Immunotherapy and Radiation for Prostate Cancer)

By a News Reporter-Staff News Editor at Cancer Vaccine Week -- Researchers detail new data in Oncology. According to news originating from Seattle, Washington, by NewsRx

Drug combo suppresses growth of late-stage prostate cancer tumors

By a News Reporter-Staff News Editor at Clinical Trials Week -- WEST LAFAYETTE, Ind. - Low doses of metformin, a widely used diabetes medication, and a gene inhibitor known as

Prostate cancer: Androgen receptor activates different genes when bound to antiandrogens

By a News Reporter-Staff News Editor at Biotech Week -- COLUMBUS, Ohio - The androgen receptor in prostate cancer cells can activate different sets of genes depending on whether it

Researchers' Work from University of Montreal Focuses on Prostate Cancer (Sexual partners, sexually transmitted infections, and prostate cancer risk)

By a News Reporter-Staff News Editor at Cancer Weekly -- New research on Oncology is the subject of a report. According to news originating from Montreal, Canada, by NewsRx

Smoking may increase risks for patients being treated for prostate cancer

By a News Reporter-Staff News Editor at Cancer Weekly -- Among patients with prostate cancer, those who smoke have increased risks of experiencing side effects from treatment and

Cardinal Health to manufacture Bayer cancer drug in new Indiana facility

Bayer HealthCare and Cardinal Health have signed a 15-year agreement for the contract manufacturing of the castration-resistant prostate cancer drug Xofigo (radium Ra 223

A yardstick to measure the malignancy of prostate cancer

By a News Reporter-Staff News Editor at Cancer Weekly -- When cancer is diagnosed, the grade of its malignancy is a central concern for both patients and their physicians. This

Testing for drug-resistant bacteria before prostate biopsy can reduce infections

By a News Reporter-Staff News Editor at Biotech Week -- PROVIDENCE, R.I. - Some infections after prostate biopsy due to drug-resistant Escherichia coli can be thwarted by simple

Common prostate cancer treatment associated with decreased survival in older men

By a News Reporter-Staff News Editor at Cancer Weekly -- DETROIT - A common prostate cancer therapy should not be used in men whose cancer has not spread beyond the prostate

Targeted Freezing Technique Increases Cure Rates/Life Quality in Men With Prostate Cancer

By a News Reporter-Staff News Editor at Cancer Vaccine Week -- A new 10-year study on men with prostate cancer has shown that those who underwent a procedure to treat their tumors

HIV drug blocks bone metastases in prostate cancer

By a News Reporter-Staff News Editor at AIDS Weekly -- (PHILADELPHIA) - Although prostate cancer can be successfully treated in many men, when the disease metastasizes to the bone

New Prostate Cancer Findings from University of Virginia Described (The convergence of DNA damage checkpoint pathways and androgen receptor signaling...

New Prostate Cancer Findings from University of Virginia Described (The convergence of DNA damage checkpoint pathways and androgen receptor signaling in prostate cancer) By a News

New Prostate Cancer Findings from Peter MacCallum Cancer Center Outlined (Researching Depression in Prostate Cancer Patients: Factors, Timing, and...

New Prostate Cancer Findings from Peter MacCallum Cancer Center Outlined (Researching Depression in Prostate Cancer Patients: Factors, Timing, and Measures) By a News Reporter-

Data from Fudan University Provide New Insights into Prostate Cancer (Intensity-modulated radiation therapy for pancreatic and prostate cancer using...

Data from Fudan University Provide New Insights into Prostate Cancer (Intensity-modulated radiation therapy for pancreatic and prostate cancer using pulsed low-dose rate delivery

Reports Outline Prostatectomy Findings from Department of Anesthesiology (Association of anesthesia technique for radical prostatectomy with...

Reports Outline Prostatectomy Findings from Department of Anesthesiology (Association of anesthesia technique for radical prostatectomy with biochemical recurrence: a retrospective

Investigators at Emory University Describe Findings in Prostate Cancer (Comparison of Image-guided Radiotherapy Technologies for Prostate Cancer)

By a News Reporter-Staff News Editor at Cancer Weekly -- Investigators publish new report on Oncology. According to news reporting originating in Atlanta, Georgia, by NewsRx

NCI -UPenn researchers find radiation plus hormone therapy prolongs survival for older men with prostate cancer

ENP Newswire - 07 January 2015 Release date- 06012015 - PHILADELPHIA - Adding radiation treatment to hormone therapy saves more lives among older men with locally advanced prostate

Reports from George Washington University Describe Recent Advances in Prostate Cancer (Advances in systemic therapies for metastatic...

Reports from George Washington University Describe Recent Advances in Prostate Cancer (Advances in systemic therapies for metastatic castration-resistant prostate cancer) By a News

Data on Prostate Cancer Described by Researchers at University of Michigan (Urinary biomarkers for prostate cancer)

By a News Reporter-Staff News Editor at Cancer Weekly -- New research on Oncology is the subject of a report. According to news reporting originating in Ann Arbor, Michigan, by

Researchers at Medical University of South Carolina Release New Data on Prostate Cancer (Salvage radical prostatectomy as management of locally...

Researchers at Medical University of South Carolina Release New Data on Prostate Cancer (Salvage radical prostatectomy as management of locally recurrent prostate cancer: outcomes

Research Conducted at University of California Has Updated Our Knowledge about Prostate Cancer (Diagnostic associations of gene expression signatures...

Research Conducted at University of California Has Updated Our Knowledge about Prostate Cancer (Diagnostic associations of gene expression signatures in prostate cancer tissue) By

New Prostate Cancer Study Findings Recently Were Reported by Researchers at Vanderbilt University (Prostate cancer metastases alter bone mineral and...

New Prostate Cancer Study Findings Recently Were Reported by Researchers at Vanderbilt University (Prostate cancer metastases alter bone mineral and matrix composition independent

How does prostate cancer form?

By a News Reporter-Staff News Editor at Cancer Gene Therapy Week -- (PHILADELPHIA) - Prostate cancer affects more than 23,000 men this year in the USA however the individual genes